Germer M, Kanse S M, Kirkegaard T, Kjøller L, Felding-Habermann B, Goodman S, Preissner K T
Haemostasis Research Unit, Kerckhoff-Klinik, Max-Planck-Institute, Bad Nauheim, Germany.
Eur J Biochem. 1998 May 1;253(3):669-74. doi: 10.1046/j.1432-1327.1998.2530669.x.
Distinct binding interactions between cell-surface receptors and extracellular matrix components are characteristic of multifunctional adhesion proteins such as vitronectin. The close proximity of binding sites for alpha(v)-integrins and plasminogen activator inhibitor-1 (PAI-1) on vitronectin may have consequences for cell adhesion and migration, or for the localized inhibition of plasminogen activators. In this study, the kinetics and reversibility of vitronectin-dependent cell adhesion via alpha(v)-integrins was investigated using RGD peptides and PAI-1 as competitors. Active, but not latent or cleaved PAI-1, and RGD peptides were effective in preventing cell adhesion to vitronectin provided the inhibitor was present at the time of cell seeding. In a concentration-dependent manner urokinase or thrombin abrogated the inhibitory effect of PAI-1. Following cell seeding onto a vitronectin substratum, delayed addition of RGD peptides or active PAI-1 (10-20 min post-seeding) resulted in the loss of their inhibitory potential. These data were supported by experiments in a purified system where delayed addition of active PAI-1 could no longer prevent vitronectin binding to immobilized alpha(v)beta3, while a cyclic RGD peptide gave some moderate inhibition. The apparent stabilization of vitronectin-integrin contacts was observed with immobilized native or multimeric vitronectin but not with the more rigid form of denatured, aggregated multimers. These results demonstrate that the cell adhesive properties of vitronectin depend on its conformational flexibility and can be tightly regulated in a spatio-temporal manner through direct competition of cellular integrins by soluble or matrix-bound factors such as PAI-1.
细胞表面受体与细胞外基质成分之间独特的结合相互作用是多功能黏附蛋白(如玻连蛋白)的特征。玻连蛋白上α(v)整合素和纤溶酶原激活物抑制剂-1(PAI-1)结合位点的紧密相邻可能会对细胞黏附与迁移,或对纤溶酶原激活物的局部抑制产生影响。在本研究中,使用RGD肽和PAI-1作为竞争者,研究了通过α(v)整合素依赖玻连蛋白的细胞黏附的动力学和可逆性。活性PAI-1(而非潜伏型或裂解型PAI-1)以及RGD肽在细胞接种时存在抑制剂的情况下,能有效阻止细胞黏附于玻连蛋白。尿激酶或凝血酶以浓度依赖方式消除了PAI-1的抑制作用。在将细胞接种到玻连蛋白基质上后,延迟添加RGD肽或活性PAI-1(接种后10 - 20分钟)导致其失去抑制潜力。在纯化系统中的实验支持了这些数据,在该系统中延迟添加活性PAI-1不再能阻止玻连蛋白与固定化的α(v)β3结合,而环状RGD肽有一定程度的抑制作用。使用固定化的天然或多聚体玻连蛋白可观察到玻连蛋白-整合素接触的明显稳定,而变性、聚集多聚体这种更刚性的形式则不然。这些结果表明,玻连蛋白的细胞黏附特性取决于其构象灵活性,并且可通过可溶性或基质结合因子(如PAI-1)与细胞整合素的直接竞争,以时空方式进行严格调控。